Hamzeh M Halawani1, Hani Tamim2, Farah Khalifeh3, Aurélie Mailhac2, Faek R Jamali4. 1. Department of Surgery, American University of Beirut Medical Center, Cairo Street, Riad El Solh, PO Box 11-0236, Beirut, 1107 2020, Lebanon. 2. Clinical Research Institute, American University of Beirut Medical Center, Beirut, Lebanon. 3. Department of Immunology and Microbiology, American University of Beirut Medical Center, Beirut, Lebanon. 4. Department of Surgery, American University of Beirut Medical Center, Cairo Street, Riad El Solh, PO Box 11-0236, Beirut, 1107 2020, Lebanon. fj03@aub.edu.lb.
Abstract
BACKGROUND: The debate regarding the merits of routine use of intraoperative cholangiography (IOC) during laparoscopic cholecystectomy (LC) continues to rage. We aim to analyze the American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP) database to identify patterns of utilization of cholangiography during LC as well as its impact on patient outcomes. STUDY DESIGN: This is a retrospective cohort study of patients undergoing LC with or without IOC in the 2012 and 2013 ACS NSQIP database. Only patients without any preoperative biochemical evidence of the CBD stone were included in the analysis. Comparison between two groups and data analysis focused on the following primary outcomes: 30-day mortality, readmission, return to operating room and NSQIP collected morbidity. RESULTS: Twenty-one percentage of patients undergoing LC without any biochemical abnormality are undergoing IOC. There were no statistically significant differences in thirty-day outcomes between two patient populations with regard to mortality, morbidity, cardiac, central nervous system, wound, deep vein thrombosis, sepsis, respiratory and urinary tract complications. Patients undergoing LC plus IOC were found to have statistically significant reduction in the rate of readmission related to the first operation (adjusted odds ratio 0.80, 95 % CI 0.70-0.92; P value = 0.002). Readmissions related to biliary complications including retained CBD following cholecystectomy were 1.61 times more likely in patients who underwent LC without cholangiography. CONCLUSION: The use of IOC at the time of LC appears to be associated with a statistically significant decrease in re-admission rates, especially readmissions related to biliary complications.
BACKGROUND: The debate regarding the merits of routine use of intraoperative cholangiography (IOC) during laparoscopic cholecystectomy (LC) continues to rage. We aim to analyze the American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP) database to identify patterns of utilization of cholangiography during LC as well as its impact on patient outcomes. STUDY DESIGN: This is a retrospective cohort study of patients undergoing LC with or without IOC in the 2012 and 2013 ACS NSQIP database. Only patients without any preoperative biochemical evidence of the CBD stone were included in the analysis. Comparison between two groups and data analysis focused on the following primary outcomes: 30-day mortality, readmission, return to operating room and NSQIP collected morbidity. RESULTS: Twenty-one percentage of patients undergoing LC without any biochemical abnormality are undergoing IOC. There were no statistically significant differences in thirty-day outcomes between two patient populations with regard to mortality, morbidity, cardiac, central nervous system, wound, deep vein thrombosis, sepsis, respiratory and urinary tract complications. Patients undergoing LC plus IOC were found to have statistically significant reduction in the rate of readmission related to the first operation (adjusted odds ratio 0.80, 95 % CI 0.70-0.92; P value = 0.002). Readmissions related to biliary complications including retained CBD following cholecystectomy were 1.61 times more likely in patients who underwent LC without cholangiography. CONCLUSION: The use of IOC at the time of LC appears to be associated with a statistically significant decrease in re-admission rates, especially readmissions related to biliary complications.
Entities:
Keywords:
Bile duct injury; Common bile duct stones; Intraoperative cholangiography; Laparoscopic cholecystectomy
Authors: Matthew S Metcalfe; Thao Ong; Martin H Bruening; Harish Iswariah; Simon A Wemyss-Holden; Guy J Maddern Journal: Am J Surg Date: 2004-04 Impact factor: 2.565
Authors: A M Paganini; M Guerrieri; J Sarnari; A De Sanctis; G D'Ambrosio; G Lezoche; S Perretta; E Lezoche Journal: Surg Endosc Date: 2006-11-16 Impact factor: 4.584
Authors: Kristin M Sheffield; Yimei Han; Yong-Fang Kuo; Courtney M Townsend; James S Goodwin; Taylor S Riall Journal: J Am Coll Surg Date: 2012-02-25 Impact factor: 6.113
Authors: Khaled M Musallam; Hani M Tamim; Toby Richards; Donat R Spahn; Frits R Rosendaal; Aida Habbal; Mohammad Khreiss; Fadi S Dahdaleh; Kaivan Khavandi; Pierre M Sfeir; Assaad Soweid; Jamal J Hoballah; Ali T Taher; Faek R Jamali Journal: Lancet Date: 2011-10-05 Impact factor: 79.321
Authors: F A Alvarez; M de Santibañes; M Palavecino; R Sánchez Clariá; O Mazza; G Arbues; E de Santibañes; J Pekolj Journal: Br J Surg Date: 2014-03-24 Impact factor: 6.939
Authors: Leonora S F Boogerd; Henricus J M Handgraaf; Volkert A L Huurman; Hwai-Ding Lam; J Sven D Mieog; Wendeline J van der Made; Cornelis J H van de Velde; Alexander L Vahrmeijer Journal: Surg Innov Date: 2017-04-29 Impact factor: 2.058
Authors: Alba Manuel-Vázquez; Raquel Latorre-Fragua; Carmen Ramiro-Pérez; Aylhin López-Marcano; Farah Al-Shwely; Roberto De la Plaza-Llamas; José Manuel Ramia Journal: World J Gastroenterol Date: 2017-04-28 Impact factor: 5.742
Authors: Pouya Iranmanesh; Olivier Tobler; Sandra De Sousa; Axel Andres; Jean-Louis Frossard; Philippe Morel; Christian Toso Journal: PLoS One Date: 2018-06-28 Impact factor: 3.240
Authors: Labrinus van Manen; Henricus J M Handgraaf; Michele Diana; Jouke Dijkstra; Takeaki Ishizawa; Alexander L Vahrmeijer; Jan Sven David Mieog Journal: J Surg Oncol Date: 2018-06-24 Impact factor: 3.454